Cadmium, follicle-stimulating hormone, and effects on bone in women age 42-60 years, NHANES III
Cadmium, follicle-stimulating hormone, and effects on bone in women age 42-60 years, NHANES III
复制标题
DOI:
10.1016/j.envres.2009.09.012
复制
发表时间:
2010-01-01
影响因子:
8.3
通讯作者:
Kovach, John S.
中科院分区:
文献类型:
--
作者:
Gallagher, Carolyn M.;Moonga, Baljit S.;Kovach, John S.
Background: Increased body burden of environmental cadmium has been associated with greater risk of decreased bone mineral density (BMD) and osteoporosis in middle-aged and older women, and an inverse relationship has been reported between follicle-stimulating hormone (FSH) and BMD in middle-aged women; however, the relationships between cadmium and FSH are uncertain, and the associations of each with bone loss have not been analyzed in a single population.Objectives: The objective of this study was to evaluate the associations between creatinine-adjusted urinary cadmium (UCd) and FSH levels, and the associations between UCd and FSH with BMD and osteoporosis, in postmenopausal and perimenopausal women aged 42-60 years.Methods: Data were obtained from the Third National Health Examination and Nutrition Survey, 19881994 (NHANES III). Outcomes evaluated were serum FSH levels, femoral bone mineral density measured by dual energy X-ray absorptiometry, and osteoporosis indicated by femoral BMD cutoffs based on the international standard. Urinary cadmium levels were analyzed for association with these outcomes, and FSH levels analyzed for association with bone effects, using multiple regression. Subset analysis was conducted by a dichotomous measure of body mass index (BMI) to proxy higher and lower adipose-synthesized estrogen effects.Results: UCd was associated with increased serum FSH in perimenopausal women with high BMI (n = 642; beta = 0.45; p